The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Abstract
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Papp, K. A., Gottlieb, A. B., Naldi, L., Pariser, D. M., Ho, V., Goyal, K., Fakharzadeh, S. S., Chevrier, M. R., Calabro, S., Langholff, W. K., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.10.025 · Cited by 4
Self-citationRetractedInfluence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Self-citationEtanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Self-citationGuidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.039 · Cited by 1,222
Self-citationEtanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Self-citationTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Self-citationAnti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Self-citationMease, P. J., Gladman, D. D., Ritchlin, C. T., Ruderman, E. M., Steinfeld, S. D., Choy, E. H. S., Sharp, J. T., Ory, P. A., Perdok, R. J., & Weinberg, M. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21306 · Cited by 909
Blauvelt, A., Papp, K. A., Griffiths, C. E. M., Randazzo, B., Wasfi, Y., Shen, Y.-K., Li, S., & Kimball, A. B. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.11.041 · Cited by 897
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Self-citationAdalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889
Self-citationEtanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
Mease, P. J., Kivitz, A. J., Burch, F. X., Siegel, E. L., Cohen, S. B., Ory, P., Salonen, D., Rubenstein, J., Sharp, J. T., & Tsuji, W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20335 · Cited by 882
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Griffiths, C. E. M., Strober, B. E., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0810652 · Cited by 859
Self-citationPhase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Gordon, K. B., Blauvelt, A., Papp, K. A., Langley, R. G., Luger, T., Ohtsuki, M., Reich, K., Amato, D., Ball, S. G., Braun, D. K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512711 · Cited by 848
Self-citationGriffiths, C. E. M., Reich, K., Lebwohl, M., van de Kerkhof, P., Paul, C., Menter, A., Cameron, G. S., Erickson, J., Zhang, L., Secrest, R. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60125-8 · Cited by 834
Self-citationPhase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Lebwohl, M., Strober, B., Menter, A., Gordon, K., Weglowska, J., Puig, L., Papp, K., Spelman, L., Toth, D., Kerdel, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503824 · Cited by 828
Self-citationJørgensen, K. K., Olsen, I. C., Goll, G. L., Lorentzen, M., Bolstad, N., Haavardsholm, E. A., Lundin, K. E. A., Mørk, C., Jahnsen, J., Kvien, T. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30068-5 · Cited by 818
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Self-citationMcInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., Brodmerkel, C., Li, S., Wang, Y., Mendelsohn, A. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60594-2 · Cited by 807
Self-citationPsoriasis prevalence among adults in the United States
Rachakonda, T. D., Schupp, C. W., & Armstrong, A. W. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.11.013 · Cited by 783
Self-citationReich, K., Armstrong, A. W., Foley, P., Song, M., Wasfi, Y., Randazzo, B., Li, S., Shen, Y.-K., & Gordon, K. B. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.11.042 · Cited by 761
Self-citationSaurat, J. ‐., Stingl, G., Dubertret, L., Papp, K. A., Langley, R. G. B., Ortonne, J. ‐., Unnebrink, K., Kaul, M., Camez, A., & for the CHAMPION Study Investigators (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08315.x · Cited by 728
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C., Krueger, G. G., de Vlam, K., Birbara, C., Beutler, A., Guzzo, C., Zhou, B., Dooley, L. T., & Kavanaugh, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032268 · Cited by 715
Self-citationPapp, K. A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C. E. M., Nakanishi, A. M., Zitnik, R., van de Kerkhof, P. C. M., & the Etanercept Psoriasis Study Group (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06688.x · Cited by 693
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis
Sommer, D. M., Jenisch, S., Suchan, M., Christophers, E., & Weichenthal, M. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0703-z · Cited by 667
Antoni, C. E., Kavanaugh, A., Kirkham, B., Tutuncu, Z., Burmester, G. R., Schneider, U., Furst, D. E., Molitor, J., Keystone, E., Gladman, D., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20967 · Cited by 640
Self-citationGottlieb, A., Menter, A., Mendelsohn, A., Shen, Y.-K., Li, S., Guzzo, C., Fretzin, S., Kunynetz, R., & Kavanaugh, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60140-9 · Cited by 585
Self-citationGottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., & Menter, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.021 · Cited by 581
Self-citationReich, K., Papp, K. A., Blauvelt, A., Tyring, S. K., Sinclair, R., Thaçi, D., Nograles, K., Mehta, A., Cichanowitz, N., Li, Q., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31279-5 · Cited by 569
Bartelds, G. M., Wijbrandts, C. A., Nurmohamed, M. T., Stapel, S., Lems, W. F., Aarden, L., Dijkmans, B. A. C., Tak, P. P., & Wolbink, G. J. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065615 · Cited by 562
Thaçi, D., Blauvelt, A., Reich, K., Tsai, T.-F., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Hugot, S., You, R., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.013 · Cited by 551
Kurd, S. K., & Gelfand, J. M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.09.022 · Cited by 519
Self-citationMenter, A., Feldman, S. R., Weinstein, G. D., Papp, K., Evans, R., Guzzo, C., Li, S., Dooley, L. T., Arnold, C., & Gottlieb, A. B. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.017 · Cited by 516
Self-citationRisankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Papp, K. A., Blauvelt, A., Bukhalo, M., Gooderham, M., Krueger, J. G., Lacour, J.-P., Menter, A., Philipp, S., Sofen, H., Tyring, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607017 · Cited by 514
Self-citationGordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510
Self-citationMease, P. J., Gladman, D. D., Papp, K. A., Khraishi, M. M., Thaçi, D., Behrens, F., Northington, R., Fuiman, J., Bananis, E., Boggs, R., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.07.023 · Cited by 508
A Randomized Trial of Etanercept as Monotherapy for Psoriasis
Gottlieb, A. B. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.12.1627 · Cited by 470
Self-citationSingh, J. A., Guyatt, G., Ogdie, A., Gladman, D. D., Deal, C., Deodhar, A., Dubreuil, M., Dunham, J., Husni, M. E., Kenny, S., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.23789 · Cited by 466
Self-citationGuidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Leonardi, C. L., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.055 · Cited by 460
Self-citationKimball, A. B., Gladman, D., Gelfand, J. M., Gordon, K., Horn, E. J., Korman, N. J., Korver, G., Krueger, G. G., Strober, B. E., & Lebwohl, M. G. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.01.006 · Cited by 432
Self-citationBachelez, H., van de Kerkhof, P. C. M., Strohal, R., Kubanov, A., Valenzuela, F., Lee, J.-H., Yakusevich, V., Chimenti, S., Papacharalambous, J., Proulx, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62113-9 · Cited by 410
Nash, P., Kirkham, B., Okada, M., Rahman, P., Combe, B., Burmester, G.-R., Adams, D. H., Kerr, L., Lee, C., Shuler, C. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31429-0 · Cited by 405
Self-citationPapp, K. A., Langley, R. G., Sigurgeirsson, B., Abe, M., Baker, D. R., Konno, P., Haemmerle, S., Thurston, H. J., Papavassilis, C., & Richards, H. B. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12110 · Cited by 360
Langley, R. G., Tsai, T. ‐., Flavin, S., Song, M., Randazzo, B., Wasfi, Y., Jiang, J., Li, S., & Puig, L. (2018) · British Journal of Dermatology · doi:10.1111/bjd.15750 · Cited by 341
Long-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With Psoriasis
Tyring, S., Gordon, K. B., Poulin, Y., Langley, R. G., Gottlieb, A. B., Dunn, M., & Jahreis, A. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.6.719 · Cited by 324
Self-citationSofen, H., Smith, S., Matheson, R. T., Leonardi, C. L., Calderon, C., Brodmerkel, C., Li, K., Campbell, K., Marciniak, S. J., Wasfi, Y., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.01.025 · Cited by 320
Self-citationPapp, K. A., Gottlieb, A. B., Naldi, L., Pariser, D., Ho, V., Goyal, K., Fakharzadeh, S., Chevrier, M., Calabro, S., Langholff, W., et al. (2015) · PubMed · Cited by 312
Self-citationBlauvelt, A., Reich, K., Tsai, T.-F., Tyring, S., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Vender, R., Hugot, S., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.08.008 · Cited by 312
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
Gordon, K. B., Duffin, K. C., Bissonnette, R., Prinz, J. C., Wasfi, Y., Li, S., Shen, Y.-K., Szapary, P., Randazzo, B., & Reich, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501646 · Cited by 306
Self-citationKavanaugh, A., Ritchlin, C., Rahman, P., Puig, L., Gottlieb, A. B., Li, S., Wang, Y., Noonan, L., Brodmerkel, C., Song, M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204741 · Cited by 295
Self-citationEgeberg, A., Ottosen, M. B., Gniadecki, R., Broesby-Olsen, S., Dam, T. N., Bryld, L. E., Rasmussen, M. K., & Skov, L. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16102 · Cited by 284
Kauffman, C. L., Aria, N., Toichi, E., McCormick, T. S., Cooper, K. D., Gottlieb, A. B., Everitt, D. E., Frederick, B., Zhu, Y., Graham, M. A., et al. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23448.x · Cited by 279
Self-citationPapp, K., Thaçi, D., Reich, K., Riedl, E., Langley, R. G., Krueger, J. G., Gottlieb, A. B., Nakagawa, H., Bowman, E. P., Mehta, A., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13932 · Cited by 276
Self-citationKrueger, J. G., Ferris, L. K., Menter, A., Wagner, F., White, A., Visvanathan, S., Lalovic, B., Aslanyan, S., Wang, E. E. L., Hall, D., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.018 · Cited by 256
Self-citationPharmacoeconomic Evaluation in the Real World: Effectiveness Versus Efficacy Studies
Revicki, D. A., & Frank, L. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915050-00001 · Cited by 246
Rich, P., Sigurgeirsson, B., Thaçi, D., Ortonne, J. ‐., Paul, C. F., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12112 · Cited by 244
Infliximab-Related Infusion Reactions: Systematic Review
Lichtenstein, L., Ron, Y., Kivity, S., Ben-Horin, S., Israeli, E., Fraser, G. M., Dotan, I., Chowers, Y., Confino-Cohen, R., & Weiss, B. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv096 · Cited by 239
Dommasch, E. D., Abuabara, K., Shin, D. B., Nguyen, J., Troxel, A. B., & Gelfand, J. M. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.09.734 · Cited by 223
Self-citationThomas, S. S., Borazan, N., Barroso, N., Duan, L., Taroumian, S., Kretzmann, B., Bardales, R., Elashoff, D., Vangala, S., & Furst, D. E. (2015) · BioDrugs · doi:10.1007/s40259-015-0134-5 · Cited by 213
Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease
WEST, R. L., ZELINKOVA, Z., WOLBINK, G. J., KUIPERS, E. J., STOKKERS, P. C. F., & VAN DER WOUDE, C. J. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03828.x · Cited by 213
Tsai, T.-F., Ho, J.-C., Song, M., Szapary, P., Guzzo, C., Shen, Y.-K., Li, S., Kim, K.-J., Kim, T.-Y., Choi, J.-H., et al. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.05.005 · Cited by 212
Clinical improvement in psoriasis with specific targeting of interleukin-23
Kopp, T., Riedl, E., Bangert, C., Bowman, E. P., Greisenegger, E., Horowitz, A., Kittler, H., Blumenschein, W. M., McClanahan, T. K., Marbury, T., et al. (2015) · Nature · doi:10.1038/nature14175 · Cited by 210
Mrowietz, U., Leonardi, C. L., Girolomoni, G., Toth, D., Morita, A., Balki, S. A., Szepietowski, J. C., Regnault, P., Thurston, H., & Papavassilis, C. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.04.011 · Cited by 208
Self-citationBarker, J., Hoffmann, M., Wozel, G., Ortonne, J.-P., Zheng, H., van Hoogstraten, H., & Reich, K. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10615.x · Cited by 202
Wan, J., Wang, S., Haynes, K., Denburg, M. R., Shin, D. B., & Gelfand, J. M. (2013) · BMJ · doi:10.1136/bmj.f5961 · Cited by 202
Self-citationSaeki, H., Nakagawa, H., Nakajo, K., Ishii, T., Morisaki, Y., Aoki, T., Cameron, G. S., Osuntokun, O. O., & the Japanese Ixekizumab Study Group (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.13622 · Cited by 195
Reich, K., Pinter, A., Lacour, J. P., Ferrandiz, C., Micali, G., French, L. E., Lomaga, M., Dutronc, Y., Henneges, C., Wilhelm, S., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15666 · Cited by 192
Rich, P., Sigurgeirsson, B., Thaci, D. P., Ortonne, J.-P., Paul, C., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12070 · Cited by 189
ASAHINA, A., NAKAGAWA, H., ETOH, T., OHTSUKI, M., & THE ADALIMUMAB M04‐688 STUDY GROUP (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00748.x · Cited by 184
Griffiths, C. E. M., Thaçi, D., Gerdes, S., Arenberger, P., Pulka, G., Kingo, K., Weglowska, J., on behalf of the EGALITY study group, Hattebuhr, N., Poetzl, J., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15152 · Cited by 184
Gordon, K., Papp, K., Poulin, Y., Gu, Y., Rozzo, S., & Sasso, E. H. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.005 · Cited by 181
Self-citationAntidrug antibodies in psoriasis: a systematic review
Hsu, L., Snodgrass, B. T., & Armstrong, A. W. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12654 · Cited by 164
Self-citationGottlieb, A., Sullivan, J., van Doorn, M., Kubanov, A., You, R., Parneix, A., Hugot, S., & Milutinovic, M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.058 · Cited by 159
Self-citationFiorentino, D., Ho, V., Lebwohl, M. G., Leite, L., Hopkins, L., Galindo, C., Goyal, K., Langholff, W., Fakharzadeh, S., Srivastava, B., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.07.013 · Cited by 159
Self-citationReich, K., Ortonne, J.-P., Gottlieb, A. B., Terpstra, I. J., Coteur, G., Tasset, C., & Mease, P. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10941.x · Cited by 158
Self-citationAl-Mutairi, N., & Nour, T. M. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.900541 · Cited by 156
Antoni, C., Kavanaugh, A., van der Heijde, D. M. F. M., et al. (2008) · PubMed · Cited by 156
Self-citationGottlieb, A. B., Masuda, S., Ramamurthi, R., Abdulghani, A. A., Romano, P., Chaudhari, U., Dooley, L. T., Fasanmade, A. A., & Wagner, C. L. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.10 · Cited by 153
Self-citationShelton, E., Laharie, D., Scott, F. I., Mamtani, R., Lewis, J. D., Colombel, J., & Ananthakrishnan, A. N. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.037 · Cited by 152
Zachariae, C. O. C., Mørk, N. J., Reunala, T. L., Lorentzen, H. F., Falk, E., Karvonen, S., Johannesson, A., Clareus, B., Skov, L., Mørk, G., et al. (2008) · Acta Dermato Venereologica · doi:10.2340/00015555-0511 · Cited by 148
Lecluse, L. L. A., Driessen, R. J. B., Spuls, P. I., de Jong, E. M. G. J., Stapel, S. O., van Doorn, M. B. A., Bos, J. D., & Wolbink, G. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2009.347 · Cited by 148
Steenholdt, C., Svenson, M., Bendtzen, K., Thomsen, O. Ø., Brynskov, J., & Ainsworth, M. A. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04682.x · Cited by 147
Nakagawa, H., Niiro, H., & Ootaki, K. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.10.009 · Cited by 147
Strober, B. E., Crowley, J., Yamauchi, P. S., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10419.x · Cited by 146
Self-citationChiu, H., Chen, C., Wu, M., Cheng, Y. ‐., & Tsai, T. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12461 · Cited by 144
Gottlieb, A. B., Langley, R. G. B., Strober, B. E., Papp, K. A., Klekotka, P. A., Creamer, K., Thompson, E. H. Z., Hooper, M., & Kricorian, G. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11015.x · Cited by 143
Self-citationNast, A., Jacobs, A., Rosumeck, S., & Werner, R. N. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.206 · Cited by 143
Nijsten, T. E. C., & Stern, R. S. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/s0190-9622(03)01587-1 · Cited by 140
Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune‐mediated diseases
Haynes, K., Beukelman, T., Curtis, J. R., Newcomb, C. W., Herrinton, L. J., Graham, D. J., Solomon, D. H., Griffin, M. R., Chen, L., Liu, L., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37740 · Cited by 139
Acute infusion reactions induced by monoclonal antibody therapy
Maggi, E., Vultaggio, A., & Matucci, A. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.90 · Cited by 137
Gisondi, P., Giglio, M. D., Cotena, C., & Girolomoni, G. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08564.x · Cited by 136
Safety of biologics in psoriasis
Kamata, M., & Tada, Y. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14096 · Cited by 136
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
de Vries, M. K., van der Horst-Bruinsma, I. E., Nurmohamed, M. T., Aarden, L. A., Stapel, S. O., Peters, M. J. L., van Denderen, J. C., Dijkmans, B. A. C., & Wolbink, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089979 · Cited by 135
Incidence and clinical significance of immunogenicity to infliximab in Crohnʼs disease
Cassinotti, A., & Travis, S. P. L. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20899 · Cited by 130
Lebwohl, M., Yeilding, N. M., Szapary, P. O., Wang, Y., Li, S., Zhu, Y., Reich, K., Langley, R. G. B., & Papp, K. A. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.11.012 · Cited by 130
Self-citationSaeki, H., Nakagawa, H., Ishii, T., Morisaki, Y., Aoki, T., Berclaz, P., & Heffernan, M. P. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12773 · Cited by 130
Strober, B. E., Leonardi, C. L., Papp, K. A., Mrowietz, U., Ohtsuki, M., Bissonnette, R., Ferris, L. K., Paul, C. F., Lebwohl, M., Braun, D. K., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.09.026 · Cited by 130
Self-citationGladman, D. D., Mease, P. J., Cifaldi, M. A., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057901 · Cited by 124
Strik, A. S., van den Brink, G. R., Ponsioen, C. Y., Mathôt, R. A. A., Löwenberg, M., & D’Haens, G. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13994 · Cited by 124
Motives for smoking and their correlates in clients attending Stop Smoking treatment services
McEwen, A., West, R., & McRobbie, H. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802027248 · Cited by 120
Efficacy of etanercept in an integrated multistudy database of patients with psoriasis
Gordon, K. B., Korman, N. J., Frankel, E., Wang, H., Jahreis, A., Zitnik, R. J., & Chang, T. H. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.11.1088 · Cited by 119
Self-citationPost-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea
Park, S. H., Kim, Y.-H., Lee, J. H., Kwon, H. J., Lee, S.-H., Park, D. I., Kim, H. K., Cheon, J. H., Im, J. P., Kim, Y. S., et al. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1091309 · Cited by 113
Gordon, K. B., Leonardi, C. L., Lebwohl, M., Blauvelt, A., Cameron, G. S., Braun, D. K., Erickson, J., & Heffernan, M. P. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.07.048 · Cited by 107
Self-citationBagel, J., Lynde, C. W., Tyring, S. K., Kricorian, G., Shi, Y., & Klekotka, P. A. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.07.034 · Cited by 106
Cho, I.-H., Lee, N., Song, D., Jung, S. Y., Bou-Assaf, G. M., Sosic, Z., Zhang, W., & Lyubarskaya, Y. V. (2016) · mAbs · doi:10.1080/19420862.2016.1193659 · Cited by 104
Snast, I., Atzmony, L., Braun, M., Hodak, E., & Pavlovsky, L. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.01.037 · Cited by 101
Reich, K., Leonardi, C. L., Langley, R. G. B., Warren, R. B., Bachelez, H., Romiti, R., Ohtsuki, M., Xu, W., Acharya, N. V., Solotkin, K. C., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.027 · Cited by 99
Self-citationPapp, K. A., Leonardi, C., Blauvelt, A., Reich, K., Korman, N., Ohtsuki, M., Paul, C. F., Ball, S. G., Cameron, G. S., Erickson, J., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16050 · Cited by 97
Self-citationImmunogenicity of Biotherapy Used in Psoriasis: The Science Behind the Scenes
Jullien, D., Prinz, J. C., & Nestle, F. O. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.295 · Cited by 95
Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review
Pompili, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i44.7867 · Cited by 95
Reveille, J. D., Conant, M. A., & Duvic, M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331016 · Cited by 93
Ohtsuki, M., Morita, A., Abe, M., Takahashi, H., Seko, N., Karpov, A., Shima, T., Papavassilis, C., Nakagawa, H., & subgroup, T. E. S. J. (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12668 · Cited by 92
Strober, B. E., Bissonnette, R., Fiorentino, D. F., Kimball, A. B., Naldi, L., Shear, N. H., Goyal, K., Fakharzadeh, S. S., Calabro, S., Langholff, W. K., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.017 · Cited by 89
Self-citationPoulalhon, N., Bégon, E., Lebbé, C., Lioté, F., Lahfa, M., Bengoufa, D., Morel, P., Dubertret, L., & Bachelez, H. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07639.x · Cited by 88
Kircik, L., Bagel, J., Korman, N. J., Menter, A., Elmets, C. A., Koo, J. Y. M., Yang, Y., Chiou, C., Dann, F. J., & Stevens, S. R. (2008) · PubMed · Cited by 86
Self-citationPapp, K. A., Strober, B. E., Augustin, M., Calabro, S., Londhe, A., & Chevrier, M. R. (2012) · PubMed · Cited by 84
Self-citationEfficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments
Mazzotta, A., Esposito, M., Costanzo, A., et al. (2009) · American Journal of Clinical Dermatology · doi:10.2165/11310770-000000000-00000 · Cited by 76
Wolf, P., Weger, W., Legat, F. J., Posch‐Fabian, T., Gruber‐Wackernagel, A., Inzinger, M., Salmhofer, W., & Hofer, A. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10616.x · Cited by 74
Puig, L., López‐Ferrer, A., Vilarrasa, E., & García, I. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12238 · Cited by 73
Retinoids in prevention of skin cancer
Moon, T. E., Levine, N. S., Cartmel, B., et al. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04663-6 · Cited by 68
Strober, B. E., Poulin, Y. P., Kerdel, F. A., Langley, R. G. B., Gu, Y., Gupta, S. R., Okun, M. M., & Papp, K. A. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.03.009 · Cited by 66
Self-citationBlauvelt, A., Ferris, L. K., Yamauchi, P. S., Qureshi, A. A., Leonardi, C., Farahi, K., Fakharzadeh, S. S., Hsu, M.-C., Li, S., Chevrier, M. R., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15722 · Cited by 66
Self-citationAnti-infliximab antibodies in inflammatory bowel disease
Lee, L. Y. W., Sanderson, J. D., & Irving, P. M. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835558cf · Cited by 64
Choquette, D., Faraawi, R., Chow, A., Rodrigues, J. F., Bensen, W., & Nantel, F. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140538 · Cited by 64
Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?
SIMONE, C. D., Amerio, P., Amoruso, G. F., Bardazzi, F., Campanati, A., Conti, A., Gisondi, P., Gualdi, G., Guarneri, C., Leoni, L., et al. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.848194 · Cited by 61
Yamauchi, P. S., Bissonnette, R., Teixeira, H. D., & Valdecantos, W. C. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.02.1221 · Cited by 59
Gottlieb, A. B., Lacour, J. ‐., Korman, N. J., Wilhelm, S., Dutronc, Y., Schacht, A., Erickson, J., Zhang, L., Mallbris, L., & Gerdes, S. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13990 · Cited by 56
Self-citationGottlieb, A. B., Kalb, R. E., Blauvelt, A., Heffernan, M. P., Sofen, H. L., Ferris, L. K., Kerdel, F. A., Calabro, S., Wang, J. J., Kerkmann, U., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.10.020 · Cited by 54
Self-citationGottlieb, A. B., Langley, R. G. B., Philipp, S., Sigurgeirsson, B., Blauvelt, A., Martin, R., Papavassilis, C., & Mpofu, S. (2015) · PubMed · Cited by 52
Self-citationde Vries, A. C. Q., Thio, H. B., de Kort, W. J. A., Opmeer, B. C., van der Stok, H. M., de Jong, E. M. G. J., Horváth, B., Busschbach, J. J. V., Nijsten, T. E. C., & Spuls, P. I. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14867 · Cited by 52
Menter, A., Thaçi, D., Wu, J. J., Abramovits, W., Kerdel, F. A., Arikan, D., Guo, D., Ganguli, A. X., Bereswill, M., Camez, A. A., et al. (2017) · Dermatology and Therapy · doi:10.1007/s13555-017-0198-x · Cited by 49
Self-citationThe infliximab biosimilar in the treatment of moderate to severe plaque psoriasis
Dapavo, P., Vujic, I., Fierro, M. T., Quaglino, P., & Sanlorenzo, M. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.04.068 · Cited by 47
Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series
Weng, H.-J., Wang, T. ‐., & Tsai, T. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16252 · Cited by 47
Jacobs, I. A., Petersel, D. L., Isakov, L., Lula, S., & Sewell, K. L. (2016) · BioDrugs · doi:10.1007/s40259-016-0201-6 · Cited by 46
Takeshita, J., Wang, S., Shin, D. B., Duffin, K. C., Krueger, G. G., Kalb, R. E., Weisman, J. D., Sperber, B. R., Stierstorfer, M. B., Brod, B. A., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.08.003 · Cited by 39
Self-citationBlauvelt, A., Papp, K. A., Griffiths, C. E. M., Puig, L., Weisman, J. D., Dutronc, Y., Kerr, L. F., Ilo, D., Mallbris, L., & Augustin, M. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-016-0246-9 · Cited by 38
Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis
Mugheddu, C., Atzori, L., Lappi, A., Pau, M., Murgia, S., & Rongioletti, F. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14234 · Cited by 38
Prussick, R. B., Unnebrink, K., & Valdecantos, W. C. (2015) · PubMed · Cited by 36
Elewski, B. E., Leonardi, C., Gottlieb, A. B., Strober, B. E., Simiens, M. A., Dunn, M. E., & Jahreis, A. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07585.x · Cited by 35
Self-citationChoi, Y. M., Debbaneh, M. G., Weinberg, J. M., Yamauchi, P. S., Voorhees, A. S. V., Armstrong, A. W., Siegel, M. P., & Wu, J. J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.06.014 · Cited by 34
Self-citationProfile of certolizumab and its potential in the treatment of psoriatic arthritis
Chimenti, M. S., Saraceno, R., Chiricozzi, Giunta, A., Chimenti, S., & Perricone, R. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s31658 · Cited by 32
Lee, J., Youn, J.-I., Kim, T.-Y., Choi, J.-H., Park, C.-J., Choe, Y.-B., Song, H.-J., Kim, K. J., Kim, K.-J., Lee, J., et al. (2016) · BMC Dermatology · doi:10.1186/s12895-016-0048-z · Cited by 31
de Carvalho, A. V. E., Duquia, R. P., Horta, B. L., & Bonamigo, R. R. (2016) · Drugs in R&D · doi:10.1007/s40268-016-0152-x · Cited by 31
Kircik, L., Fowler, J. F., Weiss, J., Meng, X., Guana, A., & Nyirady, J. (2016) · Dermatology and Therapy · doi:10.1007/s13555-016-0139-0 · Cited by 27
Biologics in the Treatment of Psoriasis: Clinical and Economic Overview
Poulin, Y. P., Langley, R. G. B., Teixeira, H. D., Martel, M.-J., & Cheung, S. (2009) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2009.00021 · Cited by 26
Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis
Ryoo, J. Y., Yang, H., Ji, E., & Yoo, B. K. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028015626545 · Cited by 26
Papp, K. A., Armstrong, A. W., Reich, K., Karunaratne, M., & Valdecantos, W. C. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0161-5 · Cited by 25
Self-citationCumulative False-Positive QuantiFERON-TB Interferon-γ Release Assay Results
Gamsky, T. E., Lum, T., Hung-Fan, M., & Green, J. A. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201508-532oc · Cited by 25
Duron, C., Goutte, M., Pereira, B., Bommelaer, G., & Buisson, A. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000354 · Cited by 23
Clinical Efficacy and Safety of Anti-IL-17 Agents for the Treatment of Patients with Psoriasis
Chen, Y., Qian, T., Zhang, D., Yan, H., & Hao, F. (2015) · Immunotherapy · doi:10.2217/imt.15.50 · Cited by 22
Secukinumab in the Treatment of Generalized Pustular Psoriasis: A Case report
Polesie, S., & Lidholm, A. G. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2467 · Cited by 20
Ayala, F., Lambert, J., & on Behalf of the TANGO Study Group (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2014.952611 · Cited by 16
Vender, R. B., Lynde, C. W., Gilbert, M. J., Ho, V., Sapra, S., & Poulin-Costello, M. (2013) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2012.12036 · Cited by 11
Support Needed to Involve Psoriasis Patients in Treatment Decisions: Survey of Dermatologists
Tan, J. K. L., Stacey, D., Barankin, B., Bissonnette, R., Gulliver, W. P. F., Lui, H., Shear, N. H., & Bhatti, S. (2011) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2011.10067 · Cited by 11
Effective treatment of etanercept and phototherapy-resistant psoriasis using the excimer laser
Park, K. K., Swan, J. W., & Koo, J. Y. M. (2012) · Dermatology Online Journal · doi:10.5070/d31mk9r7rb · Cited by 10
Karakawa, M., Komine, M., Kishimoto, M., Maki, N., Matsumoto, A., Sugai, J., & Ohtsuki, M. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13515 · Cited by 8
Puig, L., Camacho, F., García‐Patos, V., Fernández-Díaz, M. L., Marquina, A., & García-Calvo, C. (2015) · European Journal of Dermatology · doi:10.1684/ejd.2015.2591 · Cited by 3
Cited by
Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E., & Barker, J. N. W. N. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32549-6 · Cited by 2,383
Self-citationPathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review
Armstrong, A. W., & Read, C. (2020) · JAMA · doi:10.1001/jama.2020.4006 · Cited by 2,335
Self-citationChallenges and Future Trends in the Treatment of Psoriasis
Lee, H.-J., & Kim, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713313 · Cited by 315
Nash, P., Kerschbaumer, A., Dörner, T., Dougados, M., Fleischmann, R. M., Geissler, K., McInnes, I., Pope, J. E., van der Heijde, D., Stoffer-Marx, M., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218398 · Cited by 299
Bissonnette, R., Stein Gold, L., Rubenstein, D. S., Tallman, A. M., & Armstrong, A. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.10.085 · Cited by 181
Self-citation
Metadata
- Authors
- Menter, A., Strober, B. E., Kaplan, D. H., Kivelevitch, D., Prater, E. F., Stoff, B., Armstrong, A. W., Connor, C., Cordoro, K. M., Davis, D. M. R., Elewski, B. E., Gelfand, J. M., Gordon, K. B., Gottlieb, A. B., Kavanaugh, A., Kiselica, M., Korman, N. J., Kroshinsky, D., Lebwohl, M., Leonardi, C. L., Lichten, J., Lim, H. W., Mehta, N. N., Paller, A. S., Parra, S. L., Pathy, A. L., Rupani, R. N., Siegel, M., Wong, E. B., Wu, J. J., Hariharan, V., & Elmets, C. A.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 80
- Issue
- 4
- Pages
- 1029-1072
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2912058252
- Cited by
- 969
- References
- 161
- FWCI
- 34.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.